Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. De Backer, C. Van Holsbeke, A. Sadowska, J. De Backer, R. Claes, W. Vos (Kontich, Edegem, Belgium). Effects of high dose N-acetylcysteine in COPD patients. Eur Respir J 2012; 40: Suppl. 56, 2880

Member's Comments

Kapustina Valentina - 03.09.2012 08:25
It is a very-very interesting work!

Related content which might interest you: The influence of high doses of N-acetylcysteine alone or in combination with inhaled corticosteroids on quality of life in patients with COPD Source: Annual Congress 2011 - COPD management Year: 2011 Effect of erdosteine in moderately severe COPD patients Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 High doses of N-acetylcysteine alone or in combination with inhaled corticosteroids and oxidative stress in patients with COPD Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 Effect of oral N-acetylcysteine treatment on systemic inflammatory status in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 716s Year: 2005 The effect of long-term treatment with erdosteine on moderate or severe COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005 Effect of azithromycin treatment on inflammation in COPD patients Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Treatment of COPD: comparing the effects of inhaled steroids with N-acetylcysteine Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005 Effect of low dose theophylline as adjunct in treatment of COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Effect of suplementary dietary antioxidants in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 428s Year: 2006 The effects of adding in erdosteine on the routine bronchodilator therapy in moderate and severe COPD patients Source: Annual Congress 2006 - COPD therapy Year: 2006 Effects of roflumilast in highly symptomatic COPD patients Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Therapeutic effect of low dose roxithromycin in chronic stable mild-to-moderate asthma Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010 Effects of low dose inhaled theophylline (ADC4022) co-administered with budesonide on inflammatory markers, lung function, and quality of life in COPD patients Source: Annual Congress 2009 - New drugs for airways disease Year: 2009 Effect of theophylline in low and average doses on lung function and quality of life in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 212s Year: 2006 Effect of roflumilast on hospitalizations in COPD patients Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012 Effects of atorvastatin in asthmatic patients under treatment with high dose inhaled or oral steroid Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010 Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020 Effects of N-acetylcysteine on asthma exacerbation Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study Source: Eur Respir J, 50 (4) 1700711; 10.1183/13993003.00711-2017 Year: 2017 Efficacy and safety of single doses of inhaled LAS100977 in patients with mild to moderate asthma Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010